Clinical Trials Logo

Enteric Hyperoxaluria clinical trials

View clinical trials related to Enteric Hyperoxaluria.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05650112 Recruiting - Healthy Clinical Trials

Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria

Start date: November 16, 2022
Phase: Phase 1
Study type: Interventional

This Phase 1, first-in-human, randomized, double-blinded, placebo controlled study is evaluating FB-001 in healthy volunteers (Part 1) and participants diagnosed with enteric hyperoxaluria (Part 2). Eligible participants receive investigational product and undergo safety monitoring, evaluations and subsequent follow-up after investigational product administration.

NCT ID: NCT05124886 Recruiting - Clinical trials for Enteric Hyperoxaluria

Gut Kidney Axis in Enteric Hyperoxaluria

Start date: November 10, 2022
Phase: N/A
Study type: Interventional

40 subjects with a confirmed diagnosis of IBD or >6 months post-RYGB with a diagnosed USD event or kidney stone on imaging within the past three years and 40 healthy controls will be administered a high oxalate diet on Days 0-3 and Days 21-24 with a washout period on Days 4-7 and will be administered 250mg sodium oxalate on Days 8-20, via prepared spinach, from Weil Cornell Medicine's Clinical and Translational Science Center. Subjects will partake in four stool collections, four 24-h urine collections, two blood collections, and four sets of colonic permeability testing.